Literature DB >> 28675578

A time series analysis of the effects of financial incentives and mandatory clinical applications as interventions to improve spontaneous adverse drug reaction reporting by hospital medical staff in China.

Feng Chang1, Yue Xi1, Jie Zhao2, Xiaojian Zhang2, Yun Lu1.   

Abstract

RATIONALE, AIMS, AND
OBJECTIVES: Spontaneous reporting of adverse drug reactions (ADRs) in hospitals is often under-reported, which may lead to problems in patient management. This study was aimed to assess the effectiveness of a financial intervention based on a fine and a bonus for improving spontaneous reporting of ADRs by physicians in a hospital setting.
METHODS: This study was conducted at the First Affiliated Hospital of Zhengzhou University (China). Starting in 2009, a bonus of 20 RMB (Chinese currency) was given for each spontaneous ADR report, and a fine of 50 RMB was given for any withheld ADR report. A time series analysis using autoregressive integrated moving average models was performed to assess the changes in the total number of spontaneous ADR reports between the preintervention period (2006-2008) and during the first (2009-2011) and second (2012-2014) intervention periods.
RESULTS: The median number of reported ADRs per year increased from 29 (range 27-72) in the preintervention period to 277 (range 199-284) in the first intervention period and to 666 in the second (range 644-691). The monthly number of reported ADRs was stable during the 3 periods: 3.56 ± 3.60/month (95% confidence interval (CI), 2.42-4.75) during the preintervention period, 21 ± 13/month (95% CI, 16.97-25.80) in the first intervention period, and 56 ± 20/month (95% CI, 48.81-62.17) in the second intervention period.
CONCLUSION: A financial incentive and ADR management regulations had a significant effect on the increase of reported ADRs.
© 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adverse drug reaction; autoregressive integrated moving average (ARIMA) models; financial incentive; reporting

Mesh:

Year:  2017        PMID: 28675578     DOI: 10.1111/jep.12780

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  8 in total

1.  Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria.

Authors:  Theophilus A Adegbuyi; Joseph O Fadare; Ebisola J Araromi; Abayomi O Sijuade; Iyanu Bankole; Ilesanmi K Fasuba; Rachel A Alabi
Journal:  Hosp Pharm       Date:  2020-09-18

2.  Knowledge, Attitude, and Barriers Toward ADRs Reporting Among Health-Care Professionals at Tertiary Care Health Settings in Peshawar, Pakistan: A Web Based Study.

Authors:  Iftikhar Ali; Wiqar Ahmad; Arslan Rahat Ullah; Faheemullah Khan; Muhammad Ijaz; Sheraz Khan; Tahir Mehmood Khan
Journal:  Hosp Pharm       Date:  2020-04-21

3.  Paying for performance to improve the delivery of health interventions in low- and middle-income countries.

Authors:  Karin Diaconu; Jennifer Falconer; Adrian Verbel; Atle Fretheim; Sophie Witter
Journal:  Cochrane Database Syst Rev       Date:  2021-05-05

4.  The comparative assessment of awareness, perspective, and basic practice skills about the Saudi pharmacovigilance system among students of different health-care professionals of a Saudi Female University.

Authors:  Asmatanzeem Bepari; Rasha Assad Assiri; Maya Abdullah AlYahya; Shaden Jamaan AlGhamdi; Amal Mohammed AlGhamdi; Afrah Asaad AlOnazi
Journal:  Saudi Pharm J       Date:  2020-06-12       Impact factor: 4.330

5.  Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study.

Authors:  Kidu Gidey; Mohammedamin Seifu; Berhane Yohannes Hailu; Solomon Weldegebreal Asgedom; Yirga Legesse Niriayo
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

6.  A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.

Authors:  Mona Y Alsheikh; Moudi M Alasmari
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

7.  Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy.

Authors:  Sheraz Ali; Oluwaseun Egunsola; Dalal Salem Al-Dossari; Ibrahim Abdulaziz Al-Zaagi
Journal:  Ther Adv Drug Saf       Date:  2018-08-11

8.  Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan.

Authors:  Akash Syed; Saira Azhar; Muhammad Mohsin Raza; Humaira Saeed; Shazia Qasim Jamshed
Journal:  Pharmacy (Basel)       Date:  2018-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.